Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Live Combined Bacillus Subtilis and Enterococcus Faecium Granules with Multivitamins for Neonatal Hyperbilirubinemia
ChiCTR-IPR-15005980Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Mar 2015
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial of bacillus subtilis + enterococcus faecium + multivitamins in neonatal hyperbilirubinemia (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Transcutaneous bilirubin level. Planned start Mar 2015; status: not yet recruiting.
02
Drugs
bacillus subtilis + enterococcus faecium + multivitamins
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on ChiCTR-IPR-15005980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15005980.